ATOMOXETINE TREATMENT FOR PEDIATRIC PATIENTS WITH ADHD AND COMORBID ANXIETY
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Objectives: Research indicates 25%-50% comorbidity of anxiety disorders with attention-deficit/hyperactivity disorder (ADHD). Atomoxetine is a nonstimulant approved for treating ADHD that is not contraindicated in the presence of anxiety disorders. This study compared atomoxetine with placebo in treating pediatric patients with ADHD and comorbid anxiety, as measured by the ADHDRS-IV-Parent: Inv (ADHDRS) Total Score and the Pediatric Anxiety Rating Scale (PARS) Total Score. Methods: Patients in this double-blind, acute portion of an extended, multicenter trial were randomly assigned to approximately 12 weeks of atomoxetine treatment (n=87) or placebo (n=89). Patients met DSM-IV criteria for both ADHD and anxiety disorder (generalized anxiety, separation anxiety, or social phobia). ADHD RS and PARS total scores were analyzed using ANCOVA (LOCF). Patients who responded during a placebo lead-in period were excluded from ADHD RS and PARS (total scores) analyses. Results: Mean ADHD RS total score improved significantly from baseline to endpoint for the atomoxetine group (n=55; -10.5, SD 10.6) relative to placebo (n=58; -1.4, SD 8.3; P<.001). Mean PARS total score also improved significantly from baseline to endpoint for the atomoxetine group (n=55; -5.5, SD 4.8) relative to placebo (n=58; -3.2, SD 5.0; P=0.011). Conclusion: Results suggest atomoxetine is efficacious in pediatric patients with ADHD and comorbid anxiety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.5.564 · Cited by 1,738 · cited 11×
“3) N 55 58 78 78 *** p .001 effect size = 1.0 Eligible Patients All Patients *** p .001 effect size = 0.8 ADHD RS Total Score-MMRM (Eligible Patients) 0 5 10 15 20 25 30 35 40 0 2 4 6 8 1 0 Week Mean Score Atomoxetine Placebo Improvement ** *** *** *** *** **p .01 ***p .001 PARS Total Score -6 -5 -4 -3 -2 -1 0 Atomoxe…”
BackgroundInfluentialMichelson, D., Allen, A. J., Busner, J., Casat, C., Dunn, D., Kratochvil, C., Newcorn, J., Sallee, F. R., Sangal, R. B., Saylor, K., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1896 · Cited by 599
Self-citationKelsey, D. K., Sumner, C. R., Casat, C. D., Coury, D. L., Quintana, H., Saylor, K. E., Sutton, V. K., Gonzales, J., Malcolm, S. K., Schuh, K. J., et al. (2004) · Pediatrics · doi:10.1542/peds.114.1.e1 · Cited by 464
Self-citationSpencer, T., Heiligenstein, J. H., Biederman, J., Faries, D. E., Kratochvil, C. J., Conners, C. K., & Potter, W. Z. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1209 · Cited by 333 · cited 1×
“The efficacy of atomoxetine for treating ADHD has been demonstrated in children and adolescents when administered once daily (Kelsey et al., 2004; Michelson et al., 2002) or twice daily (Michelson et al., 2001; Spencer et al., 2002).”
Background
Cited by
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
PLISZKA, S. R., CRISMON, M. L., HUGHES, C. W., CORNERS, C. K., EMSLIE, G. J., JENSEN, P. S., McCRACKEN, J. T., SWANSON, J. M., & LOPEZ, M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000215326.51175.eb · Cited by 442
“The use of atomoxetine in the treatment of patients with ADHD and comorbid anxiety has been studied (Sumner et al., 2005).”
BackgroundResultBanaschewski, T., Coghill, D., Santosh, P., Zuddas, A., Asherson, P., Buitelaar, J., Danckaerts, M., Döpfner, M., Faraone, S. V., Rothenberger, A., et al. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0549-0 · Cited by 375
Graham, J., & Coghill, D. (2008) · CNS Drugs · doi:10.2165/00023210-200822030-00003 · Cited by 185
Pliszka, S. R. (2007) · Neuropsychology Review · doi:10.1007/s11065-006-9017-3 · Cited by 158
Prasad, S., Harpin, V., Poole, L., Zeitlin, H., Jamdar, S., Puvanendran, K., & on behalf of the SUNBEAM Study Group (2007) · Current Medical Research and Opinion · doi:10.1185/030079906x167309 · Cited by 97
Griffiths, K. R., Leikauf, J. E., Tsang, T. W., Clarke, S., Hermens, D. F., Efron, D., Williams, L. M., & Kohn, M. R. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.03.009 · Cited by 29
Metadata
- Authors
- Sumner, C., Sher, L., Sutton, V, Bakken, R., Paczkowski, M., Trzepacz, P., & Kelsey, D.
- Venue
- Neuropediatrics
- Publisher
- Georg Thieme Verlag KG
- Published
- 2006
- Volume
- 37
- Issue
- S 1
- ISSN
- 0174-304X (ISSN-L)
- 1439-1899
- OpenAlex
- W2330922939
- Cited by
- 19
- References
- 4
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.